Market Tracker

12/01 5:17pm ET

Novo Nordisk A/S (NYSE:NVO)

126.18
Delayed Data
As of Dec 01
 +0.05 / +0.04%
Today’s Change
91.51
Today|||52-Week Range
126.41
+12.66%
Year-to-Date
Is It Too Late to Get in on the Upward Move in This Medical Stock?
Dec 01 / StockNews.com - Paid Partner Content
3 Healthcare Stocks That Could Set You Up For Life
Nov 24 / MotleyFool.com - Paid Partner Content
Is Merck & Co. Stock Worth Buying Before the End of 2022?
Nov 29 / StockNews.com - Paid Partner Content
Prothena (PRTA) Earns Milestone Payment From Novo Nordisk
Nov 22 / Zacks.com - Paid Partner Content
1 High-Dividend Stock to Add to Your Portfolio if You Havenít Already
Nov 28 / StockNews.com - Paid Partner Content
 

Today’s Trading

Previous close126.13
Today’s open126.18
Day’s range125.23 - 126.41
Volume988,261
Average volume (3 months)1,581,490
Market cap$203.4B
Data as of 3:58pm ET, 12/01/2022

Growth & Valuation

Earnings growth (last year)+19.70%
Earnings growth (this year)+4.59%
Earnings growth (next 5 years)+19.19%
Revenue growth (last year)+15.27%
P/E ratio38.5
Price/Sales11.53
Price/Book25.08

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.39+0.57%
NVSNovartis0.000.00%
BMYBristol-Myers Squibb+0.59+0.73%
MRKMerck-0.29-0.26%
Data as of 4:00pm ET, 12/01/2022

Financials

Next reporting dateFebruary 1, 2023
EPS forecast (this quarter)$0.79
Annual revenue (last year)$22.4B
Annual profit (last year)$7.6B
Net profit margin33.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Bagsværd, Capital Region

Forecasts